lobbying_activities: 3151926
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3151926 | 39519a2d-317f-4669-8c52-d8df428ad067 | Q1 | THE RABEN GROUP | 61458 | BREAST CANCER PREVENTION PARTNERS (FORMERLY KNOWN AS BREAST CANCER FUND) | 2024 | first_quarter | CHM | Education on strengthening FDA authority and the safety of personal care products, including H.R. 3619 (Toxic-Free Beauty Act), H.R. 3620 (Cosmetic Safety for Communities of Color and Professional Salon Workers Act), H.R. 3621 (Cosmetic Fragrance and Flavor Ingredient Right to Know Act), H.R. 3622 (Cosmetic Supply Chain Transparency Act), proposals to regulate PFAS in cosmetic products, including H.R. 6519 (No PFAS in Cosmetics Act), and implementation of the Modernization of Cosmetics Regulation Act of 2022. Funding for Centers for Disease Control Biomonitoring program and National Health Tracking Network in Fiscal Year 2024. Proposals to reform the FDA's GRAS standard, reassess and ban food additives, and food packaging-related legislation, including H.R. 6105 (No Toxics in Food Packaging Act) and S.3387 (Ensuring Safe and Toxic-Free Foods Act). | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2024-04-18T14:37:49-04:00 |